Delivery Order SPE2DB20D1109-SPE2DB23FP41N
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $30,671.51 for the supply of OTEZLA 30 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of January 24, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $41,287.36 for the provision of OTEZLA 30 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $50,076.39 to provide 4563728675 units of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA) Troop Support Medical. The award has an ultimate completion date of February 22, 2024 and is a firm fixed price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $9,793.16, is for a delivery order of OTEZLA 30 MG TABLET 60S. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,092.73 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a completion date of December 29, 2023. This award is not designated as a set-aside contract. The DLA, which is a defense agency, is the contracting authority for this order,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $68,189.79, is for the delivery of Otezla 30 mg tablets. The contract has an ultimate completion date of September 21, 2023, and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $15,736.64 for the supply of OTEZLA 30 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. The contract is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Otezla 30 mg tablets. The award, valued at $29,493.43, was made by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 21, 2023. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $16,649.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Otezla 30 mg tablets, a prescription medication, to support military and government healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Otezla 30 mg tablets. The contract, valued at $60,126.75, is a Firm Fixed Price Delivery Order with a completion date of May 3, 2023. The award is not set-aside and was made through full and open competition. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FP41NDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $30,863.05 for the supply of OTEZLA 30 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award is likely a delivery order issued under that IDC, enabling the DLA to efficiently procure essential medications and supplies for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.9k | 6/27/23 |